Memorial Sloan Kettering Cancer Center

This study is for people with muscle-invasive bladder cancer who cannot or choose not to receive standard chemotherapy. It tests whether a short course of focused radiation (SBRT) combined with immunotherapy drugs (cemiplimab with or without fianlimab) given before bladder remova…

This study tests whether giving two drugs together—inotuzumab and blinatumomab—is safe and works well for adults newly diagnosed with B-cell acute lymphoblastic leukemia (B-ALL). It is for patients who are older or cannot handle standard chemotherapy. The goal is to see if the co…

This early-phase study tests a radioactive drug called 177Lu-DTPA-SC16.56 in people with small-cell lung cancer or neuroendocrine prostate cancer that has worsened after standard chemotherapy. The main goal is to find the safest dose and see if the treatment can control the disea…

This study tests a therapy called Meaning-Centered Psychotherapy for Latinos (MCP-L) to see if it helps reduce anxiety and depression and improve quality of life in 300 Mexican patients with advanced breast, prostate, colorectal, or thyroid cancer. Participants will be randomly a…